BR0109809A - Derivados do carbamato de 2-hidroxi-mutilina para uso antibacteriano - Google Patents

Derivados do carbamato de 2-hidroxi-mutilina para uso antibacteriano

Info

Publication number
BR0109809A
BR0109809A BR0109809-8A BR0109809A BR0109809A BR 0109809 A BR0109809 A BR 0109809A BR 0109809 A BR0109809 A BR 0109809A BR 0109809 A BR0109809 A BR 0109809A
Authority
BR
Brazil
Prior art keywords
mutiline
hydroxy
carbamate derivatives
antibacterial use
antibacterial
Prior art date
Application number
BR0109809-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Gerald Brooks
Eric Hunt
Steven Howard Gerson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0008260.2A external-priority patent/GB0008260D0/en
Priority claimed from GB0027182A external-priority patent/GB0027182D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR0109809A publication Critical patent/BR0109809A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BR0109809-8A 2000-04-04 2001-03-29 Derivados do carbamato de 2-hidroxi-mutilina para uso antibacteriano BR0109809A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0008260.2A GB0008260D0 (en) 2000-04-04 2000-04-04 Novel compounds
GB0027182A GB0027182D0 (en) 2000-11-04 2000-11-04 Novel comounds
PCT/EP2001/003594 WO2001074788A1 (en) 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use

Publications (1)

Publication Number Publication Date
BR0109809A true BR0109809A (pt) 2003-01-21

Family

ID=26244040

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109809-8A BR0109809A (pt) 2000-04-04 2001-03-29 Derivados do carbamato de 2-hidroxi-mutilina para uso antibacteriano

Country Status (21)

Country Link
US (1) US6972297B2 (https=)
EP (1) EP1268443B1 (https=)
JP (1) JP2003529593A (https=)
KR (1) KR100758441B1 (https=)
CN (1) CN1210267C (https=)
AR (1) AR030203A1 (https=)
AT (1) ATE437860T1 (https=)
AU (2) AU2001263827B2 (https=)
BR (1) BR0109809A (https=)
CA (1) CA2405132A1 (https=)
CO (1) CO5280223A1 (https=)
CZ (1) CZ20023290A3 (https=)
DE (1) DE60139382D1 (https=)
ES (1) ES2328109T3 (https=)
HU (1) HUP0300370A3 (https=)
IL (1) IL151887A0 (https=)
MX (1) MXPA02009816A (https=)
NO (1) NO324229B1 (https=)
NZ (1) NZ521536A (https=)
PL (1) PL358666A1 (https=)
WO (1) WO2001074788A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US7176310B1 (en) 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
DE60317208T2 (de) * 2002-07-24 2008-08-07 Nabriva Therapeutics Forschungs Gmbh Pleuromutilinderivate als antimikrobielle mittel
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP1863768A1 (en) * 2004-12-13 2007-12-12 Glaxo Group Limited Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl)carbamic acid 2-(s)-hydroxymutilin 14-ester
CA2591898A1 (en) * 2004-12-27 2006-07-06 Kyorin Pharmaceutical Co., Ltd. Mutilin-derivative substituted at position 12
JP2008534443A (ja) * 2005-03-10 2008-08-28 スミスクライン・ビーチャム・コーポレイション 新規な方法
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
KR100695541B1 (ko) * 2005-10-31 2007-03-16 한국단자공업 주식회사 연결터미널
WO2007079173A2 (en) * 2005-12-30 2007-07-12 Emergent Biosolutions Inc. Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
JP5322927B2 (ja) * 2007-05-24 2013-10-23 杏林製薬株式会社 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2014640A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives
JP2010100582A (ja) * 2008-10-24 2010-05-06 Kyorin Pharmaceut Co Ltd 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
EP2253617A1 (de) 2009-05-20 2010-11-24 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
ES2843723T3 (es) * 2015-06-17 2021-07-20 Nabriva Therapeutics GmbH Formulaciones farmacéuticas inyectables de lefamulina
JP7631212B2 (ja) 2019-02-27 2025-02-18 オティカラ,インコーポレーテッド 鼻、副鼻腔、および鼻咽頭組織の感染および/または炎症を治療するための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4163254B2 (ja) 1996-01-03 2008-10-08 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ムチリンのカルバモイルオキシ誘導体および抗細菌剤としてのそれらの使用
HUP0001741A3 (en) 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
FR2771008B1 (fr) 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
HUP0300370A3 (en) 2005-07-28
PL358666A1 (en) 2004-08-09
HUP0300370A2 (hu) 2003-06-28
AR030203A1 (es) 2003-08-13
CN1427827A (zh) 2003-07-02
MXPA02009816A (es) 2003-03-27
JP2003529593A (ja) 2003-10-07
CA2405132A1 (en) 2001-10-11
EP1268443A1 (en) 2003-01-02
NO20024745L (no) 2002-11-19
US6972297B2 (en) 2005-12-06
CN1210267C (zh) 2005-07-13
CZ20023290A3 (cs) 2003-03-12
KR20030011815A (ko) 2003-02-11
AU6382701A (en) 2001-10-15
ES2328109T3 (es) 2009-11-10
AU2001263827B2 (en) 2004-06-17
NZ521536A (en) 2004-05-28
IL151887A0 (en) 2003-04-10
NO324229B1 (no) 2007-09-10
ATE437860T1 (de) 2009-08-15
NO20024745D0 (no) 2002-10-02
EP1268443B1 (en) 2009-07-29
DE60139382D1 (de) 2009-09-10
CO5280223A1 (es) 2003-05-30
WO2001074788A8 (en) 2001-12-20
US20030114674A1 (en) 2003-06-19
KR100758441B1 (ko) 2007-09-14
WO2001074788A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
BR0109809A (pt) Derivados do carbamato de 2-hidroxi-mutilina para uso antibacteriano
ATE211139T1 (de) Tetrahydroimidazopyridoindoldione als cgmp spezifische pde hemmer
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
BR0014470A (pt) Inibidores de fab i
BR0014136A (pt) Composto, uso do mesmo, métodos para a preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
BR9611175A (pt) Compostos ou suas composições e uso dos mesmo
YU74892A (sh) Novi herbicidi
BR0114646A (pt) anticorpos anti-lt-beta-r humanizados
MX9708627A (es) Oxazolidinonas de diazinilo y carbazinilo espirociclicas y biciclicas.
DE59702414D1 (de) Dipeptidische benzamidine als kininogenasen-inhibitoren
TR199902995T2 (xx) 9-Oksim eritromisin t�revleri
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
ATE332903T1 (de) Kondensierte pyridoindolderivate
ATE384722T1 (de) Alkoxypyridinderivate
ATE158791T1 (de) Arylpyrazole als fungizide
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE320422T1 (de) Metalloproteinase inhibitoren
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
ATE293111T1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
ATE250610T1 (de) Kaliumkanal-blockierende mittel
ATE337002T1 (de) Topische behandlung zur vorbeugung von augeninfektionen
DE59108566D1 (de) Heteroarylmethylbenzole-Aromatasehemmer

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.